ACCESS BIO, INC.ACCESS BIO, INC.ACCESS BIO, INC.

ACCESS BIO, INC.

No trades
See on Supercharts

950130 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, immunochemical diagnosis, biosensor, and molecular diagnostic technology. Its products are diagnostic reagents that diagnose infectious diseases such as malaria, influenza, and Coronavirus. The company was founded on September 27, 2002 and is headquartered in Somerset, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

950130 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company